---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-24-000029"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:16:41.977488+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lexicon converts all preferred to 115M common; authorized shares increased to 450M

## Summary
- 2,304,147 shares of Series A Preferred automatically converted into 115,207,350 common shares on May 10, 2024.
- Authorized common stock increased from 300M to 450M via Sixth Amended and Restated Certificate of Incorporation.
- Stockholders elected Philippe Amouyal, Lonnel Coats, and Diane Sullivan as Class III directors with >241M votes each.
- Ratified charter amendment, approved executive compensation, and reappointed Ernst & Young as auditor for FY2024.

## SEC filing metadata
- accession: 0001062822-24-000029
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/lxrx-20240510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-24-000029
- JSON: https://secwatch.observer/filing/0001062822-24-000029.json
- Plain text: https://secwatch.observer/filing/0001062822-24-000029.txt

## Key facts
- Governance Changes
  LEXICON PHARMACEUTICALS, INC.: Amended and restated certificate of incorporation to increase authorized common stock from 300,000,000 to 450,000,000 shares (effective 2024-05-10).
  - Change: charter amendment
  - Effective: 2024-05-10
  source text: On May 10, 2024, we filed a Sixth Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware, which became effective on the filing date. The Sixth Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 300,000,000 to 450,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Election of Class III Directors at the 2024-05-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-10
  source text: (1) Election of Class III Directors Name of Director For Withheld Broker Non-Votes Philippe J. Amouyal 241,812,501 18,607,732 29,015,729
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024 at the 2024-05-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-05-10
  source text: (4) Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024 286,136,766 2,884,465 414,731
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the Company's Sixth Amended and Restated Certificate of Incorporation at the 2024-05-10 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2024-05-10
  source text: (2) Ratification and approval of the the Company’s Sixth Amended and Restated Certificate of Incorporation 160,676,391 1,433,806 211,035
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve the compensation paid to the Company's named executive officers at the 2024-05-10 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-05-10
  source text: (3) Advisory vote to approve the compensation paid to the Company’s named executive officers 253,593,322 6,203,593 623,318
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/0001062822-24-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.